Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Correction for Erker et al., "Arkadia, a Novel SUMO-Targeted Ubiquitin Ligase Involved in PML Degradation".

Erker Y, Neyret-Kahn H, Seeler JS, Dejean A, Atfi A, Levy L.

Mol Cell Biol. 2017 May 31;37(12). pii: e00193-17. doi: 10.1128/MCB.00193-17. Print 2017 Jun 15. No abstract available.

2.

SUMO and the robustness of cancer.

Seeler JS, Dejean A.

Nat Rev Cancer. 2017 Mar;17(3):184-197. doi: 10.1038/nrc.2016.143. Epub 2017 Jan 30. Review.

PMID:
28134258
3.

Sumoylation coordinates the repression of inflammatory and anti-viral gene-expression programs during innate sensing.

Decque A, Joffre O, Magalhaes JG, Cossec JC, Blecher-Gonen R, Lapaquette P, Silvin A, Manel N, Joubert PE, Seeler JS, Albert ML, Amit I, Amigorena S, Dejean A.

Nat Immunol. 2016 Feb;17(2):140-9. doi: 10.1038/ni.3342. Epub 2015 Dec 14.

PMID:
26657003
4.

Sumoylation at chromatin governs coordinated repression of a transcriptional program essential for cell growth and proliferation.

Neyret-Kahn H, Benhamed M, Ye T, Le Gras S, Cossec JC, Lapaquette P, Bischof O, Ouspenskaia M, Dasso M, Seeler J, Davidson I, Dejean A.

Genome Res. 2013 Oct;23(10):1563-79. doi: 10.1101/gr.154872.113. Epub 2013 Jul 26.

5.

Arkadia, a novel SUMO-targeted ubiquitin ligase involved in PML degradation.

Erker Y, Neyret-Kahn H, Seeler JS, Dejean A, Atfi A, Levy L.

Mol Cell Biol. 2013 Jun;33(11):2163-77. doi: 10.1128/MCB.01019-12. Epub 2013 Mar 25. Erratum in: Mol Cell Biol. 2017 May 31;37(12 ):.

6.

Human male infertility associated with mutations in NR5A1 encoding steroidogenic factor 1.

Bashamboo A, Ferraz-de-Souza B, Lourenço D, Lin L, Sebire NJ, Montjean D, Bignon-Topalovic J, Mandelbaum J, Siffroi JP, Christin-Maitre S, Radhakrishna U, Rouba H, Ravel C, Seeler J, Achermann JC, McElreavey K.

Am J Hum Genet. 2010 Oct 8;87(4):505-12. doi: 10.1016/j.ajhg.2010.09.009. Erratum in: Am J Hum Genet. 2010 Nov 12;87(5):736.

7.

PARP-1 transcriptional activity is regulated by sumoylation upon heat shock.

Martin N, Schwamborn K, Schreiber V, Werner A, Guillier C, Zhang XD, Bischof O, Seeler JS, Dejean A.

EMBO J. 2009 Nov 18;28(22):3534-48. doi: 10.1038/emboj.2009.279. Epub 2009 Sep 24.

8.

Human BAHD1 promotes heterochromatic gene silencing.

Bierne H, Tham TN, Batsche E, Dumay A, Leguillou M, Kernéis-Golsteyn S, Regnault B, Seeler JS, Muchardt C, Feunteun J, Cossart P.

Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13826-31. doi: 10.1073/pnas.0901259106. Epub 2009 Aug 3.

9.

Functional interaction of AIRE with PIAS1 in transcriptional regulation.

Ilmarinen T, Kangas H, Kytömaa T, Eskelin P, Saharinen J, Seeler JS, Tanhuanpää K, Chan FY, Slattery RM, Alakurtti K, Palvimo JJ, Ulmanen I.

Mol Immunol. 2008 Apr;45(7):1847-62.

PMID:
18083234
10.

An acetylation/deacetylation-SUMOylation switch through a phylogenetically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity.

Stankovic-Valentin N, Deltour S, Seeler J, Pinte S, Vergoten G, Guérardel C, Dejean A, Leprince D.

Mol Cell Biol. 2007 Apr;27(7):2661-75. Epub 2007 Feb 5.

11.

SUMO, the three Rs and cancer.

Seeler JS, Bischof O, Nacerddine K, Dejean A.

Curr Top Microbiol Immunol. 2007;313:49-71. Review.

PMID:
17217038
12.

Role of SUMO in the dynamics of telomere maintenance in fission yeast.

Xhemalce B, Riising EM, Baumann P, Dejean A, Arcangioli B, Seeler JS.

Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):893-8. Epub 2007 Jan 5.

13.

Role of the fission yeast SUMO E3 ligase Pli1p in centromere and telomere maintenance.

Xhemalce B, Seeler JS, Thon G, Dejean A, Arcangioli B.

EMBO J. 2004 Oct 1;23(19):3844-53. Epub 2004 Sep 9.

14.

Nuclear and unclear functions of SUMO.

Seeler JS, Dejean A.

Nat Rev Mol Cell Biol. 2003 Sep;4(9):690-9. Review.

PMID:
14506472
15.

Coordinated methyl and RNA binding is required for heterochromatin localization of mammalian HP1alpha.

Muchardt C, Guilleme M, Seeler JS, Trouche D, Dejean A, Yaniv M.

EMBO Rep. 2002 Oct;3(10):975-81. Epub 2002 Sep 13.

16.

The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase.

Kirsh O, Seeler JS, Pichler A, Gast A, Müller S, Miska E, Mathieu M, Harel-Bellan A, Kouzarides T, Melchior F, Dejean A.

EMBO J. 2002 Jun 3;21(11):2682-91.

17.

The nucleoporin RanBP2 has SUMO1 E3 ligase activity.

Pichler A, Gast A, Seeler JS, Dejean A, Melchior F.

Cell. 2002 Jan 11;108(1):109-20.

18.

SUMO: of branched proteins and nuclear bodies.

Seeler JS, Dejean A.

Oncogene. 2001 Oct 29;20(49):7243-9. Review.

19.

Common properties of nuclear body protein SP100 and TIF1alpha chromatin factor: role of SUMO modification.

Seeler JS, Marchio A, Losson R, Desterro JM, Hay RT, Chambon P, Dejean A.

Mol Cell Biol. 2001 May;21(10):3314-24.

20.

c-Jun and p53 activity is modulated by SUMO-1 modification.

Muller S, Berger M, Lehembre F, Seeler JS, Haupt Y, Dejean A.

J Biol Chem. 2000 May 5;275(18):13321-9.

21.

The PML nuclear bodies: actors or extras?

Seeler JS, Dejean A.

Curr Opin Genet Dev. 1999 Jun;9(3):362-7. Review.

PMID:
10377280
22.

Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment.

Seeler JS, Marchio A, Sitterlin D, Transy C, Dejean A.

Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7316-21.

23.

Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains.

Grignani F, Testa U, Rogaia D, Ferrucci PF, Samoggia P, Pinto A, Aldinucci D, Gelmetti V, Fagioli M, Alcalay M, Seeler J, Grignani F, Nicoletti I, Peschle C, Pelicci PG.

EMBO J. 1996 Sep 16;15(18):4949-58.

25.

Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies.

Carvalho T, Seeler JS, Ohman K, Jordan P, Pettersson U, Akusjärvi G, Carmo-Fonseca M, Dejean A.

J Cell Biol. 1995 Oct;131(1):45-56.

26.
27.

Transcription factor PRDII-BF1 activates human immunodeficiency virus type 1 gene expression.

Seeler JS, Muchardt C, Suessle A, Gaynor RB.

J Virol. 1994 Feb;68(2):1002-9.

28.

Regulatory elements involved in tax-mediated transactivation of the HTLV-I LTR.

Seeler JS, Muchardt C, Podar M, Gaynor RB.

Virology. 1993 Oct;196(2):442-50.

PMID:
8372429
29.

Transcription factor AP-2 activates gene expression of HTLV-I.

Muchardt C, Seeler JS, Nirula A, Gong S, Gaynor R.

EMBO J. 1992 Jul;11(7):2573-81.

30.

Regulation of HTLV-I gene expression by tax and AP-2.

Muchardt C, Seeler JS, Gaynor RB.

New Biol. 1992 May;4(5):541-50.

PMID:
1515417
31.

Regulation of human immunodeficiency virus enhancer function by PRDII-BF1 and c-rel gene products.

Muchardt C, Seeler JS, Nirula A, Shurland DL, Gaynor RB.

J Virol. 1992 Jan;66(1):244-50.

Supplemental Content

Loading ...
Support Center